Cubist Systematic Strategies, LLC 9 Meters Biopharma, Inc. Transaction History

Cubist Systematic Strategies, LLC

5 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2022 Aug 15, 2022	SELL	$0.26 - $0.64 $156 - $384	-600 Closed	0 $0
Q1 2022 May 16, 2022	BUY	$0.52 - $1.0 $312 - $600	600 New	600 $0
Q3 2021 Nov 15, 2021	SELL	$1.03 - $1.41 $214,838 - $294,099	-208,581 Closed	0 $0
Q2 2021 Aug 16, 2021	BUY	$1.04 - $1.5 $172,516 - $248,821	165,881 Added 388.48%	208,581 $229,000
Q1 2021 May 17, 2021	BUY	$0.84 - $2.16 $35,868 - $92,232	42,700 New	42,700 $50,000

67.9K

Ticker NMTR
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 12,955,400
Market Cap $259K
Description
9 Meters Biopharma, Inc., a clinical-stage biopharmaceutical company, focuses on treatments for people with rare digestive diseases, gastrointestinal conditions with unmet needs, and debilitating disorders. The company is developing Larazotide, an 8-amino acid peptide, which is in Phase 3 clinical trial for the treatment of celiac disease, as we...

Get notified when there are updates to the investment portfolio of Cubist Systematic Strategies, LLC, based on Form 13F filings with the SEC.

Stay updated on Cubist Systematic Strategies, LLC with notifications on news.